Consultations for clinical features of possible cancer and associated urgent referrals before and during the COVID-19 pandemic: an observational cohort study from English primary care.

Consultations for clinical features of possible cancer and associated urgent referrals before and during the COVID-19 pandemic: an observational cohort study from English primary care.
复制标题

DOI:
10.1038/s41416-021-01666-6
复制
发表时间:
2022-04
影响因子:
8.8
通讯作者:
Bankhead CR
Bankhead CR
中科院分区:
医学1区
文献类型:
--
作者:
Nicholson BD;Ordóñez-Mena JM;Lay-Flurrie S;Sheppard JP;Liyanage H;McGagh D;Sherlock J;Williams J;Smith M;Drakesmith CW;Thomas NPB;Morris EJA;Perera R;de Lusignan S;Hobbs FDR;Bankhead CR

文献摘要

参考文献

被引文献

相似文献

It remains unclear to what extent reductions in urgent referrals for suspected cancer during the COVID-19 pandemic were the result of fewer patients attending primary care compared to GPs referring fewer patients. Cohort study including electronic health records data from 8,192,069 patients from 663 English practices. Weekly consultation rates, cumulative consultations and referrals were calculated for 28 clinical features from the NICE suspected cancer guidelines. Clinical feature consultation rate ratios (CRR) and urgent referral rate ratios (RRR) compared time periods in 2020 with 2019. Consultations for cancer clinical features decreased by 24.19% (95% CI: 24.04–24.34%) between 2019 and 2020, particularly in the 6–12 weeks following the first national lockdown. Urgent referrals for clinical features decreased by 10.47% (95% CI: 9.82–11.12%) between 2019 and 2020. Overall, once patients consulted with primary care, GPs urgently referred a similar or greater proportion of patients compared to previous years. Due to the significant fall in patients consulting with clinical features of cancer there was a lower than expected number of urgent referrals in 2020. Sustained efforts should be made throughout the pandemic to encourage the public to consult their GP with cancer clinical features.
DOI: 10.1016/s1470-2045(20)30391-0
发表时间: 2020-08
期刊: The Lancet. Oncology
影响因子: --
作者:
Hamilton W
通讯作者: Hamilton W
DOI: 10.1016/s2589-7500(21)00017-0ac.uk
发表时间: 2021-04-01
影响因子: 30.8
作者:
Mansfield, Kathryn E.;Mathur, Rohini;Langan, Sinead M.
通讯作者: Langan, Sinead M.
DOI: 10.1002/ijc.33277
发表时间: 2020-11-07
影响因子: 6.4
作者:
Lai, Jennifer;Mak, Vivian;Gildea, Carolynn
通讯作者: Gildea, Carolynn
DOI: 10.1136/bmjopen-2016-011092
发表时间: 2016-04-20
期刊: BMJ open
影响因子: 2.9
作者:
Correa A;Hinton W;McGovern A;van Vlymen J;Yonova I;Jones S;de Lusignan S
通讯作者: de Lusignan S
DOI: 10.1186/2052-1839-13-9
发表时间: 2013-10-31
期刊: BMC hematology
影响因子: --
作者:
Howell, Debra A;Smith, Alexandra G;Roman, Eve
通讯作者: Roman, Eve